The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)
Clinical trial NCT05084911 · COMPLETED
Trial details
- NCT number
- NCT05084911
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2023-03-24
- Enrollment
- 1807
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.